Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases. In their study reported in the Sept. 25 issue of Cell Reports, investigators from the Massachusetts General Hospital (MGH) Cancer Center identified several different classes of pancreatic CTCs and found unexpected factors that may prove to be targets for improved treatment of the deadly tumor.
"Our ability to combine a novel microfluidic CTC isolation device, developed here at MGH, with single-cell RNA sequencing has given us new biological insights into these cells and revealed novel avenues to try and block the spread of cancer," says lead author David T. Ting, MD, MGH Cancer Center.
Pancreatic cancer is among the most deadly of tumors because it spreads rapidly via CTCs carried in the bloodstream. The earliest technologies for isolating CTCs from blood samples relied on interactions with known tumor-specific marker proteins, potentially missing cells that did not express those particular markers. The device used in the current study, called the CTC-iChip, enables the isolation of all CTCs in a blood sample, regardless of the proteins they express on their surface, by removing all other components. Since the CTCs collected are in solution, unlike with previous CTC capture devices, they are suitable for advanced RNA sequencing techniques to reveal the gene expression patterns of each individual cell.
Using a well-known mouse model of pancreatic cancer, the researchers first isolated 168 single CTCs from the bloodstreams of five individual mice. Analysis of the RNA transcripts of each CTC revealed several different subsets of CTCs, based on gene expression patterns that were different from each other and from the primary tumor. The largest subset, which the authors call 'classic CTCs,' was found to have elevated expression of a stem cell gene called Aldh1 a2, along with genes characteristic of two basic cell types -- epithelial and mesenchymal -- transition between which has been associated with tumor metastasis. Another gene expressed by almost all classic CTCs, Igfbp5, is only expressed in primary tumor at locations where epithelial cancer cells interface with the supporting stromal cells that provide a nurturing microenvironment, an observation that suggests that those regions may be the source of CTCs.
The research team was most surprised to observe that extracellular matrix (ECM) genes in general -- usually expressed primarily in stromal cells -- were highly expressed in all classic CTCs. Previous studies have suggested that the establishment of metastases depends on the appropriate cellular microenvironment -- 'soil' in which CTCs can plant themselves as 'seeds'- and that the expression of ECM genes is an important aspect of that environment. Expression of ECM genes by CTCs themselves suggests that the blood-borne cells may provide or help prepare their own 'soil.'
Analysis of CTCs from blood samples of human patients with pancreatic, breast or prostate cancer also found elevated expression of several ECM genes. One particular gene, SPARC, was highly expressed in all pancreatic CTCs as well as in 31 percent of breast CTCs. Further experiments revealed that suppressing SPARC expression in human pancreatic cancer cells reduced their ability to migrate and invade tissue, and significantly fewer metastases were generated when SPARC-suppressed pancreatic tumors were implanted into a mouse model, supporting the protein's role in a tumor's metastatic potential.
"Given our limited therapeutic options for pancreatic cancer, understanding the role of the ECM in this tumor seems to be of great importance," says Ting, who is an assistant professor of Medicine at Harvard Medical School. "Much effort has been focused on targeting the microenvironment to improve the efficacy of chemotherapy, and data indicating that environmental stromal cells can enhance a tumor's metastatic ability indicate that ECM proteins are important whether they are produced in stroma or within the tumor cells themselves. Now we need to investigate whether therapeutically targeting ECM can destroy both the tumor microenvironment and CTCs before they have a chance to metastasize."
Story Source:
The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.
Link:
Gene expression patterns in pancreatic circulating tumor cells revealed
- Mass. Law About Stem Cell Research - Massachusetts Trial ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Theres a New Anti-ALS Association Ice Bucket Challenge [Last Updated On: August 23rd, 2014] [Originally Added On: August 23rd, 2014]
- Expert: Catholic objections wont leave ALS fundraiser all wet [Last Updated On: August 23rd, 2014] [Originally Added On: August 23rd, 2014]
- Inner Cell Mass - Embryonic Development & Stem Cells ... [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Mass production of placenta stem cells gets FDA approval ... [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Siamab Therapeutics Appoints Robert Mashal to Board of Directors [Last Updated On: October 9th, 2014] [Originally Added On: October 9th, 2014]
- Brain Tumor Stem Cell Lab - Massachusetts General Hospital ... [Last Updated On: October 9th, 2014] [Originally Added On: October 9th, 2014]
- 107.23 /$ (5 p.m.) [Last Updated On: October 15th, 2014] [Originally Added On: October 15th, 2014]
- Stem Cell Eye Treatment May Restore Vision [Last Updated On: October 16th, 2014] [Originally Added On: October 16th, 2014]
- Scientists Engineer Cancer-Killing Stem Cells [Last Updated On: October 26th, 2014] [Originally Added On: October 26th, 2014]
- Stem Cell Therapy, Stem Cell Biology at Mass General Hospital [Last Updated On: October 31st, 2014] [Originally Added On: October 31st, 2014]
- Harvard researchers genetically 'edit' human blood stem cells [Last Updated On: November 6th, 2014] [Originally Added On: November 6th, 2014]
- Human blood stem cells genetically 'edited' [Last Updated On: November 7th, 2014] [Originally Added On: November 7th, 2014]
- Critical Mass of Stem Cells Sets Off Embryonic Development ... [Last Updated On: November 12th, 2014] [Originally Added On: November 12th, 2014]
- Reprogramming cells, long term [Last Updated On: November 18th, 2014] [Originally Added On: November 18th, 2014]
- Pain and itch neurons grown in a dish [Last Updated On: November 25th, 2014] [Originally Added On: November 25th, 2014]
- Blood test could pick up risk of cancer five years in advance, say Harvard scientists [Last Updated On: November 28th, 2014] [Originally Added On: November 28th, 2014]
- The obesity pill that could replace exercise by turning 'bad' fat to 'good' [Last Updated On: December 9th, 2014] [Originally Added On: December 9th, 2014]
- Stem cells: The black box of reprogramming [Last Updated On: December 11th, 2014] [Originally Added On: December 11th, 2014]
- Canadian scientists crack stem cell reprogramming code [Last Updated On: December 11th, 2014] [Originally Added On: December 11th, 2014]
- Proteins drive cancer cells to change states [Last Updated On: December 16th, 2014] [Originally Added On: December 16th, 2014]
- Massachusetts (Stem Cell) - what-when-how [Last Updated On: February 3rd, 2015] [Originally Added On: February 3rd, 2015]
- New Organ Liver Prize Gathers Momentum [Last Updated On: February 4th, 2015] [Originally Added On: February 4th, 2015]
- MIT researchers develop glucose-responsive diabetes treatment [Last Updated On: February 11th, 2015] [Originally Added On: February 11th, 2015]
- Scientists develop novel technique for finding drugs to combat malaria [Last Updated On: February 11th, 2015] [Originally Added On: February 11th, 2015]
- Could we soon have man-made blood? [Last Updated On: March 10th, 2015] [Originally Added On: March 10th, 2015]
- Protein that repels immune cells protects transplanted pancreatic islets from rejection [Last Updated On: March 10th, 2015] [Originally Added On: March 10th, 2015]
- Researchers identify a vital protein that can determine head and brain development [Last Updated On: March 13th, 2015] [Originally Added On: March 13th, 2015]
- Biomedical engineer developing nanomaterial for healing broken bones [Last Updated On: March 18th, 2015] [Originally Added On: March 18th, 2015]
- Scientists engineer toxin-secreting stem cells to treat ... [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Cloning/Embryonic Stem Cells - Genome.gov [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Stem Cell Facts - University of Massachusetts Medical School [Last Updated On: July 27th, 2016] [Originally Added On: July 27th, 2016]
- Stem Cell FAQ - Massachusetts General Hospital, Boston, MA [Last Updated On: July 27th, 2016] [Originally Added On: July 27th, 2016]
- Stem-cell-based therapy promising for treatment of breast ... [Last Updated On: September 26th, 2016] [Originally Added On: September 26th, 2016]
- What Are Stem Cells? - Massachusetts General Hospital ... [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- New England Cord Blood Bank - Cord Blood and Cord Tissue ... [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- Stem cell controversy - Wikipedia [Last Updated On: December 1st, 2016] [Originally Added On: December 1st, 2016]
- From Stem Cells to Human Development - September 2016 ... [Last Updated On: December 4th, 2016] [Originally Added On: December 4th, 2016]
- X4 joins hands with Yale on rare disease program - FierceBiotech [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- TGF-1: ALS Astrocytes' Secret Sauce? - ALS Research Forum [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- CRISPR fixes disease gene in viable human embryos - Nature.com [Last Updated On: August 6th, 2017] [Originally Added On: August 6th, 2017]
- Current humanized mice not good models for studying stem cell transplants, say researchers - Scope (blog) [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- Mouse Model of Human Immune System Inadequate for Stem Cell ... - Technology Networks [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- ORGANOID - Science Magazine [Last Updated On: August 27th, 2017] [Originally Added On: August 27th, 2017]
- Asymmetrex Introduces New Contract Service For Producing ... - PR Web (press release) [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- For Lowell native, stem cell match becomes a match as friends - Lowell Sun [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Lymphoma Patient's Brain Tumor Disappeared After She Received JCAR017, Study Reports - Lymphoma News Today [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com [Last Updated On: September 2nd, 2017] [Originally Added On: September 2nd, 2017]
- Alternate Methods for Preparing Pluripotent Stem Cells ... [Last Updated On: September 25th, 2017] [Originally Added On: September 25th, 2017]
- Cloning/Embryonic Stem Cells - National Human Genome ... [Last Updated On: July 5th, 2018] [Originally Added On: July 5th, 2018]
- Boston, MA, Stem Cell Transplant, Weston, Nantucket ... [Last Updated On: January 10th, 2019] [Originally Added On: January 10th, 2019]
- Chronic variable stress activates hematopoietic stem cells ... [Last Updated On: April 12th, 2019] [Originally Added On: April 12th, 2019]
- Massachusetts Stem Cells | Stem Cell TV [Last Updated On: September 10th, 2019] [Originally Added On: September 10th, 2019]
- Comparison of Merus N.V. (MRUS) and Sage Therapeutics Inc. (NASDAQ:SAGE) - MS Wkly [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- Reviewing Cellectis S.A. (CLLS)'s and Magenta Therapeutics Inc. (NASDAQ:MGTA)'s results - MS Wkly [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- New study reveals why breast cancer spreads to the brain - USC News [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- Arkuda bags $44M to target progranulin and head off inherited dementia - FierceBiotech [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments - PR Web [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Exercise found to block chronic inflammation in mice - Harvard Gazette [Last Updated On: November 9th, 2019] [Originally Added On: November 9th, 2019]
- Top Emerging Technologies of the Year - Technowize [Last Updated On: December 29th, 2019] [Originally Added On: December 29th, 2019]
- Firm adds a new wrinkle to anti-aging products - Williamson Daily News [Last Updated On: January 5th, 2020] [Originally Added On: January 5th, 2020]
- Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018 - BioSpace [Last Updated On: January 10th, 2020] [Originally Added On: January 10th, 2020]
- 10 Of The Biggest World Revelations In The 21st Century - World Atlas [Last Updated On: February 29th, 2020] [Originally Added On: February 29th, 2020]
- Infrared Laser Treatment of TBI, PTSD, and Depression: An Expert Perspective - Psychiatry Advisor [Last Updated On: April 3rd, 2020] [Originally Added On: April 3rd, 2020]
- Startup targets glioblastoma tumors with CAR-T therapy - FierceBiotech [Last Updated On: May 28th, 2020] [Originally Added On: May 28th, 2020]
- Massachusetts Eye and Ear Enters Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder - Newswise [Last Updated On: July 2nd, 2020] [Originally Added On: July 2nd, 2020]
- Targeted Therapy for Non-Hodgkin Lymphoma: Current Progress and Future Plans - Cancer Therapy Advisor [Last Updated On: September 5th, 2020] [Originally Added On: September 5th, 2020]
- Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech [Last Updated On: October 24th, 2020] [Originally Added On: October 24th, 2020]
- NurOwn May Be Given to Early ALS Patients in US Who Finished Phase... - ALS News Today [Last Updated On: December 20th, 2020] [Originally Added On: December 20th, 2020]
- Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium - GlobeNewswire [Last Updated On: February 1st, 2021] [Originally Added On: February 1st, 2021]
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily [Last Updated On: February 1st, 2021] [Originally Added On: February 1st, 2021]
- On systemic sources of early life stress, and empathetic responses - MIT News [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- Asymmetrex Will Present a New Test for Therapeutic Stem Cell Potency at the ISSCR 2021 Annual Meeting - PRNewswire [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- Infertility: Men account for at least half of cases. So why have women shouldered the blame? - The Irish Times [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- cGVHD Paradigm Gains Systemic Options Beyond Steroids, But Real-World Data Are Required - OncLive [Last Updated On: October 28th, 2021] [Originally Added On: October 28th, 2021]
- Stem cells: Sources, types, and uses - Medical News Today [Last Updated On: December 24th, 2021] [Originally Added On: December 24th, 2021]
- Liso-Cel Outperforms Standard Therapy in Improving QoL in Relapsed/Refractory LBCL - www.oncnursingnews.com/ [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]
- January 2022: 2021 Papers of the year - Environmental Factor Newsletter [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]
- MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults... [Last Updated On: March 25th, 2022] [Originally Added On: March 25th, 2022]
- Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners - The New York Academy of Sciences [Last Updated On: April 6th, 2022] [Originally Added On: April 6th, 2022]